An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)
Clinical trial NCT01026376 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT01026376
- Sponsor
- Janssen-Cilag Farmaceutica Ltda.
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
- Start date
- 2008-06-01
- Primary completion
- 2011-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.